![](/img/cover-not-exists.png)
F36Long-term survival in patients with metastatic castration resistant prostate cancer (mCRPC) treated with enzalutamide in a named patient programs (NPP)
Tamma, A.V., Guida, A., Masini, C., Omarini, C., Clo', V., Gelsomino, F., Mighali, P., Sabbatini, R.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv341.36
Date:
October, 2015
File:
PDF, 31 KB
english, 2015